non-dilutive funding – Musely, a telemedicine and prescription skincare provider, secured $360M in non-dilutive capital designed to avoid equity dilution.
A $360 million funding deal is giving Musely room to grow without diluting existing shareholders, a move that highlights how some cash-generative health and wellness startups are rethinking financing.
Misryoum reports that Musely. a direct-to-consumer telemedicine platform focused on compounded treatments for skin. hair. and menopause care. secured more than $360 million from General Catalyst’s Customer Value Fund (CVF).. The centerpiece of the arrangement is “non-dilutive” capital, meaning it is structured to avoid a traditional equity stake being taken.
In plain terms, CVF’s model is designed around predictable business performance.. Instead of issuing common equity. the fund provides financing that is repaid through a capped. fixed share linked to revenue generated from the company’s use of the capital.. Musely’s leadership said this was notably more favorable than both a standard bank loan and a potentially dilutive venture round.
This matters because the cost of growth is often the real bottleneck for direct-to-consumer brands. Even when demand is strong, scaling customer acquisition can be expensive, and traditional fundraising can force founders to trade control and ownership for cash.
Musely said it has been cash flow positive for years and that it has consistently declined traditional VC approaches in the past.. The company’s history also reflects its shift in business model: it began in 2014 as a wellness community before pivoting toward prescription skincare in 2019.. Today, Musely operates through asynchronous consultations with board-certified clinicians, supporting access to prescription products.
From an industry perspective, Musely’s approach signals a broader financing shift. When companies can demonstrate steady revenue generation, alternative structures like capped revenue-linked repayment can preserve ownership while still funding growth.
Misryoum notes that the capital is intended to back efforts including sales and marketing. as well as other customer acquisition initiatives.. Musely joins a CVF portfolio that includes other consumer-focused companies. while the fund’s financing is managed through its own structure and separate capital pool.
For readers watching the startup economy. deals like this offer a clear takeaway: the “best” financing path increasingly depends on revenue predictability.. As more health and consumer brands build durable cash flow. they may be able to fund expansion with less dilution than in earlier funding cycles.